Optimeos Life Sciences
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$5.83M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Optimeos Life Sciences is a biotechnology company developing a novel nanoparticle platform for the intracellular delivery of RNA, DNA, and other medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optimeos Life Sciences Comparables
Compare Optimeos Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoVation Therapeutics | 83% | |
| Zy Therapeutics | 80% | |
| POP Biotechnologies, Inc. | 78% |
Optimeos Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Grant | Apr 9, 2024 | ||||
| Seed | Aug 2, 2023 | ||||
| Grant | Oct 4, 2021 | ||||
| VC Round | May 17, 2021 |
Optimeos Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| JSR Life Sciences | Seed |
| Anzu Partners | Seed |
| Hatch Biofund | Seed Round |
| 7G Bioventures | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$1M raised in Seed Round.
- Apr 9, 2024
$288K grant received from National Institute of Allergy and Infectious Diseases.
Recent news
Latest coverage and updates
- is_developingJun 25, 2026
Optimeos Life Sciences, Inc. is developing proprietary nanoparticle platform for the intracellular delivery of therapeutic macromolecules on Jun 22nd '26.
Optimeos Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Optimeos Life Sciences's valuation, stock price, and market status.
Is Optimeos Life Sciences a public or private company?
Optimeos Life Sciences is a private company.
What is the current stock price of Optimeos Life Sciences?
Optimeos Life Sciences is a private company with no public stock price. No recent secondary market data is available.
How much is Optimeos Life Sciences worth (valuation)?
Valuation information for Optimeos Life Sciences is not publicly available.
Can I buy Optimeos Life Sciences stock?
Optimeos Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Optimeos Life Sciences's last funding round?
Optimeos Life Sciences's most recent funding round was Seed Round on June 3, 2026.
Who are the main investors in Optimeos Life Sciences?
Key investors in Optimeos Life Sciences include JSR Life Sciences, 7G Bioventures.
Will Optimeos Life Sciences IPO soon?
No public IPO plans have been announced for Optimeos Life Sciences.
How can I track Optimeos Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Optimeos Life Sciences's secondary market activity and sign up for updates.